Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may
stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML).